| Investor Type | Firm |
| Type of Fund | VC |
| Stages | Early Stage, Seed |
| Investing | Canada • Israel |
Endiya is a venture capital firm based in India that positions itself as an early-stage investor targeting Seed to pre-Series A funding rounds. The fund specializes in writing the first cheque for product startups and is known for stepping in when the risk is highest, sometimes contributing up to $2 million in the initial seed round. Endiya's extensive portfolio features market-creating innovations and category-defining companies across diverse sectors.
They focus on enterprise technology with a keen interest in digital enterprise and infosec technology, and industrial tech & intelligent mobility, including industrial robotics, fabless semiconductors, edge AI, electric mobility, and autonomous driving. In the healthcare and life sciences domain, Endiya invests in startups working on AI diagnosis, chronic disease management, and cell therapy.
Additionally, they explore fintech opportunities in digital lending, alternate investments, and equity management for private markets. Endiya's thematic investment strategy allows them to identify and bet on long-standing market trends, leveraging their collective experience in building and scaling companies. The VC is composed of operator VCs who bring deep domain expertise, entrepreneurial experience, and a global network to support their portfolio companies' growth potential.
Moreover, Endiya's approach emphasizes partnership with dedicated entrepreneurs who aim to solve well-defined problems through disruptive solutions and create products that build deep customer relationships and scale globally. Through investments in firms like AquaExchange, Darwinbox, Eyestem, Kissht, Mylo, Qapita, Scrut Automation, SigTuple, and Sugar.fit, among others, the VC attracts risk-takers and founders passionate about sustainable and profitable growth, addressing large and growing markets.

